Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,990,683 | 1,958,633 | 5,678,514 | 6,494,953 | 6,670,810 |
| Marketable Securities | 3,155,825 | 3,428,021 | N/A | N/A | N/A |
| Other current assets | 217,460 | 414,465 | 322,985 | 236,875 | 135,923 |
| TOTAL | $5,363,968 | $5,801,119 | $6,001,499 | $6,731,828 | $6,806,733 |
| Non-Current Assets | |||||
| PPE Net | 13,563 | 13,674 | 17,840 | 15,322 | 21,857 |
| Investments And Advances | 290,040 | 311,354 | 262,979 | 247,753 | 239,927 |
| Intangibles | 0 | 0 | 136,009 | 0 | 150,415 |
| Other Non-Current Assets | 124,774 | 79,881 | 78,121 | 227,579 | 93,747 |
| TOTAL | $428,377 | $404,909 | $494,949 | $490,654 | $505,946 |
| Total Assets | $5,792,345 | $6,206,028 | $6,496,448 | $7,222,482 | $7,312,679 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 12,000 | N/A | 45,706 |
| Accounts payable and accrued liabilities | 23,712 | 25,127 | 27,743 | 14,029 | 35,226 |
| Accrued Expenses | 104,324 | 111,469 | 138,288 | 119,417 | 122,148 |
| Other current liabilities | 3,613 | 8,921 | 27,525 | 13,941 | 31,342 |
| TOTAL | $141,484 | $556,249 | $215,045 | $266,758 | $244,899 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 311,716 | N/A | 403,337 |
| Other Non-Current Liabilities | 166,197 | 119,477 | 112,208 | 538,576 | 103,380 |
| TOTAL | $114,891 | $69,737 | $386,117 | $507,195 | $483,198 |
| Total Liabilities | $256,375 | $625,986 | $601,162 | $773,953 | $728,097 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 713,549 | 727,950 | 739,522 | 738,722 | 805,846 |
| Retained earnings | 460,398 | 395,580 | 671,469 | 576,172 | 727,287 |
| Other shareholders' equity | 354,555 | 409,051 | 442,029 | 475,865 | 467,035 |
| TOTAL | $5,535,970 | $5,580,042 | $5,895,286 | $6,448,529 | $6,584,582 |
| Total Liabilities And Equity | $5,792,345 | $6,206,028 | $6,496,448 | $7,222,482 | $7,312,679 |